Biofarm Eyes Nearly RON325M Turnover In 2023, Up 17% Vs 2022

05.11.2023 By Ecaterina Craciun

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) estimates a turnover of approximately RON325 million for 2023, up 17% versus 2022 level, and a 6% higher net profit compared to 2022 when it reported a net result of RON71 million, the company said on Thursday (May 11).

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: Biofarm; , earnings

Comment

Username:
Password: